CANADIAN PATENTED DRUG PRICES DECLINED .3% FOR FIRST HALF OF 1993
Executive Summary
CANADIAN PATENTED DRUG PRICES DECLINED .3% FOR FIRST HALF OF 1993 from the same period in 1992, the Canadian Patented Medicine Prices Review Board reports in its January 1994 Bulletin. This is the first time that the Patented Medicine Price Index, which measures patented drug prices at the manufacturer level, has declined. The decline comes at a time when the Canadian Consumer Price Index rose 1.9% and the pharmaceutical component of the Industrial Product Price Index was up 1.3%.